Plunkett Research Online: Aridis Pharmaceuticals Inc

ARIDIS PHARMACEUTICALS INC (ARDS:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections......



Aridis Pharmaceuticals Inc
Ticker: ARDS
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 408 385-1742
Fax: 408 960-3822
Address: 5941 Optical Court
San Jose, CA 95138 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Contacts Description

Vu Truong CEO/Chief Scientific Officer/Co-Founder/Director
Fred Kurland CFO
See More
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections......See More See More

Auditor: Mayer Hoffman McCann P.C.
Legal Advisor:
$USD, 2019 2018 2017 2016
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: